303
Participants
Start Date
August 19, 2014
Primary Completion Date
February 9, 2017
Study Completion Date
April 28, 2025
Alectinib
Participants will receive alectinib 600 mg orally (four 150 mg capsules) BID from Visit 0 (baseline) until disease progression, unacceptable toxicity, withdrawal of consent or death.
Crizotinib
Participants will receive crizotinib 250 mg capsules orally BID from Visit 0 (baseline) until disease progression, unacceptable toxicity, withdrawal of consent or death.
Tuen Mun Hospital, Hong Kong
CHUV, Lausanne
Kinghorn Cancer Centre, Darlinghurst
Royal North Shore Hospital, St Leonards
Calvary Mater Newcastle, Waratah
Hospital General Univ. de Alicante, Alicante
Inselspital Bern, Bern
Monash Health Translational Precinct, Victoria
Universitaetsspital Basel, Basel
Queen Elizabeth Hospital, Adelaide
UniversitätsSpital Zürich, Zurich
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano
King Chulalongkorn Memorial Hospital, Patumwan
National Cancer Inst., Bangkok
National Cancer Center, Gyeonggi-do
Clinical Center of Serbia, Belgrade
Kasr Eieny Uni Hospital, Cairo
Seoul National University Bundang Hospital, Gyeonggi-do
Instituto Nacional De Enfermedades Respiratorias, Mexico City
Irccs Istituto Nazionale Dei Tumori (Int), Milan
Irccs Istituto Europeo Di Oncologia (IEO), Milan
Institute for pulmonary diseases of Vojvodina, Kamenitz
Trakya University Medical Faculty Research And Practice Hospital Medical Oncology Department, Edirne
Hospital Universitario Puerta de Hierro, Madrid
University of Miami-Deerfield Beach, Deerfield Beach
Hopital Haut Leveque, Pessac
SCRI Oncology Partners, Nashville
Chu Grenoble - Hopital Albert Michallon, Grenoble
Khonkaen Hospital, Khonkaen
Taichung Veterans General Hospital, Taichung
Hospital Universitario Virgen del Rocio, Seville
A.O. Universitaria Di Parma, Parma
Inonu University Medical Faculty Turgut Ozal Medical Center Medical Oncology Department, Malatya
Meir Medical Center, Kfar Saba
Ospedale Provinciale Santa Maria Delle Croci, Ravenna
Karmanos Cancer Institute, Detroit
Chiang Rai Prachanukroh Hospital, Chiang Rai
CHRU de Lille, Lille
Washington Uni School of Medicine, St Louis
Centre Leon Berard, Lyon
Irccs Ist. Tumori Giovanni Paolo Ii, Bari
University Clinical Center Sarajevo, Sarajevo
University of Texas M.D. Anderson Cancer Center, Houston
Lviv State Oncology Regional Treatment and Diagnostic Centre, Lviv
University of Colorado Cancer Center, Aurora
Songklanagarind Hospital, Songkhla
TMPN/ Cancer Care Associates, Redondo Beach
North Valley Hem Onc Med Grp, Northridge
Az Ospedaliera Nuovo Garibaldi Quartiere Nesima, Catania
N.N.Burdenko Main Military Clinical Hospital, Moscow
National University Hospital, Singapore
Moscow City Oncology Hospital #62, Moscovskaya Oblast
National Cancer Centre, Singapore
SPb City Clin Onc Dsp, Saint Petersburg
Scientific Research Oncology Institute named after N.N. Petrov, Saint Petersburg
Shanghai Pulmonary Hospital, Shanghai
Sun Yet-sen University Cancer Center, Guangzhou
Rambam Medical Center, Haifa
Centro Internacional de Estudios Clínicos (CIEC), Santiago
Massachusetts General Hospital Cancer Center, Boston
Beth Israel Deaconess Med Ctr, Boston
Dana Farber Can Ins, Boston
Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo
Cross Cancer Institute, Edmonton
Sunnybrook Odette Cancer Centre, Toronto
Mount Sinai Hospital, Toronto
Saskatoon Cancer Centre, Saskatoon
Clinica CIMCA, San José
Pamela Youde Nethersole Eastern Hospital, Hong Kong
Princess Margaret Hospital, Hong Kong
Queen Mary Hospital, Hong Kong
Uni of Auckland, Auckland
Grupo Angeles, Guatemala City
Prince of Wales Hosp, Hong Kong
Policlinico Umberto i di Roma, Rome
Azienda Ospedaliera Di Perugia Ospedale s. Maria Della Misericordia, Perugia
Uniwersyteckie Centrum Kliniczne, Gda?sk
Ms Clinsearch Specjalistyczny Niepubliczny Zaklad Opieki Zdrowotnej, Lublin
Warminsko-Mazurskie Centrum Chorób P?uc w Olsztynie, Olsztyn
Centrum Onkologii - Inst.Im. Marii Sklodowskiej-Curie, Warsaw
CHUC - Unidade de Pneumologia Oncológica, Coimbra
IPO de Lisboa, Lisbon
IPO do Porto, Porto
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Barcelona
Hospital Universitari Germans Trias i Pujol, Barcelona
National Cheng Kung Univ Hosp, Tainan City
National Taiwan University Hospital, Taipei
Taipei Veterans General Hospital, Taipei
Baskent University Adana Dr. Turgut Noyan Practice and Research Hospital, Adana
Ankara University Medical Faculty, Ankara
Kyiv Regional Oncological Dispensary, Kyiv
Birmingham Heartlands Hospital, Birmingham
University College London Hospital, London
Guys & St Thomas Hospital, London
Hoffmann-La Roche
INDUSTRY